Guzman and collegues demonstrate that it is possible to specifically target leukemic stem/progenitor cells with the naturally occurring small molecule parthenolide. These findings open new avenues for the treatment of hematological malignancies.
|Number of pages||1|
|Publication status||Published - Jun 1 2005|
ASJC Scopus subject areas